Daniel Oliver: Building a "Facebook" for investments in biotech startups
- Spain
- 4 min read
- Apr 09, 2021
- By Emanuela Ferraro
© CompassList
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Founded in 2015, Capital Cell was the first European platform for equity crowdfunding in biotechnology and health startups. With nearly €15m in investments from 35 funding rounds, the company today counts 7,000 registered investors, making it one of Spain’s biggest health-tech private investment networks.
Capital Cell CEO and founder Daniel Oliver believes that one of the fundamental problems for biotech companies is access to funding but for investors putting their money into biotech and health solutions, it is not the same as investing in SaaS or e-commerce. It requires know-how that...
Capital Cell CEO and founder Daniel Oliver believes that one of the fundamental problems for biotech companies is access to funding but for investors putting their money into biotech and health solutions, it is not the same as investing in SaaS or e-commerce. It requires know-how that...
The rest of the content is only available if you are logged in.
MOST VIEWED
RECOMMENDED